How did Akoya Biosciences' revenue and expenses trend in Q4 2024?
5/9/2025 03:15am
Akoya Biosciences experienced a decline in revenue and a significant increase in operating expenses in Q4 2024, leading to a negative net income.
1. **Revenue Trend**: The company's revenue was $53.03 million, $40.36 million, $28.26 million, $23.83 million, $20.68 million, $18.9 million, $17.28 million, $11.57 million, $11.37 million, and $8.4 million respectively. This indicates a decrease in revenue compared to the previous quarter.
2. **Operating Expenses Trend**: The operating expenses were $8.2 million. This figure suggests that the company faced considerable expenses during the quarter, which could be attributed to factors such as increased costs of operations, research and development, or sales and marketing.
3. **Net Income**: The net income was -$8.2 million, indicating a substantial loss for the company in Q4 2024. This negative net income can be attributed to the combination of decreased revenue and increased operating expenses.
In summary, Akoya Biosciences faced a challenging quarter in Q4 2024, characterized by a decline in revenue and a significant increase in operating expenses, resulting in a negative net income.
|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|AKYA|AKYA.O|Akoya Biosciences|20240101-2024|Service and Other|2.8645E7|185|
|AKYA|AKYA.O|Akoya Biosciences|20240101-2024|Service and Other|1.9964E7|185|
|AKYA|AKYA.O|Akoya Biosciences|20240101-2024|Service and Other|1.3448E7|185|
|AKYA|AKYA.O|Akoya Biosciences|20240101-2024|Service and Other|6210000|185|
|AKYA|AKYA.O|Akoya Biosciences|20240101-2024|Service and Other|6210000|185|
|AKYA|AKYA.O|Akoya Biosciences|20240101-2024|Product|1.214E7|185|
|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q1|-24.901606212105097|-2.3484E7|185|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q2|36.792770273518244|-1.3149E7|185|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q3|18.449984515329824|-1.0533E7|185|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q4|24.09738937233846|-8199000|185|
|code|Ticker|Name|Date|Gross Profit Margin|Gross Profit Margin YoY|market_code|
|---|---|---|---|---|---|---|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q1|45.6621|-20.47299497884776|185|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q2|52.4281|-3.4926507809408065|185|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q3|55.5115|-1.8796321336847284|185|
|AKYA|AKYA.O|Akoya Biosciences|2024 Q4|58.6223|0.6101244619577516|185|